The Latest Breaking News from Influenza

Combination drug treatment outperformed most commonly used flu medicine Tamiflu, researchers say

Girl was sent home from Sydney Children’s hospital in Randwick twice before being admitted to Northern Beaches hospital a day later, where she died

The Health and Human Services secretary once again stands athwart biomedical progress yelling, "Stop!"

Scientists fear decision may increase vaccine hesitancy, but other countries are still willing to invest in research

Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms. These include chronic fatigue, brain fog, exercise intolerance, dizziness, muscle or joint pain and gut problems. And many of these symptoms worsen after exercise, a phenomenon known as post-exertional malaise.

Novavax, Inc. (NASDAQ:NVAX) on Thursday revealed preclinical data from the H5N1 avian pandemic influenza vaccine candidate.

Moderna Inc.’s (NASDAQ:MRNA) stock has surged approximately 37% in the last month but has dipped around 15% year to date.

Winter is here, and with it come higher rates of respiratory illnesses. If you’ve been struck down recently with a sore throat, runny nose and a cough, or perhaps even a fever, you’re not alone.

Cambodia’s Ministry of Health recently confirmed the country’s twelfth human case of H5N1 avian influenza so far this year

Cambodia’s Ministry of Health recently confirmed the country’s twelfth human case of H5N1 avian influenza so far this year. The patient, a five-year-old boy from Kampot province, is currently in intensive care with severe respiratory symptoms.

The mercury-based preservative was removed from most vaccines in 2001. Should it still be a concern today?